STOCK TITAN

TFF Pharmaceuticals, Inc. - $TFFP STOCK NEWS

Welcome to our dedicated page for TFF Pharmaceuticals news (Ticker: $TFFP), a resource for investors and traders seeking the latest updates and insights on TFF Pharmaceuticals stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TFF Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TFF Pharmaceuticals's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.02%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.19%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.12%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.07%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.22%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.7%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.14%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.14%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.51%
Tags
covid-19
TFF Pharmaceuticals, Inc.

Nasdaq:TFFP

TFFP Rankings

TFFP Stock Data

5.44M
2.23M
4.71%
13.87%
3.44%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
AUSTIN

About TFFP

tff pharmaceuticals, inc. is a clinical-stage biopharma company focused on developing and commercializing drug products based on its patented thin film freezing (tff) technology. our patented thin film freezing (tff) platform makes it possible to turn more molecules into inhalable therapies. this novel technology provides high absorption and yield, uniform particle size, gentle process and endless possibilities. tff pharmaceuticals has two lead drug candidates: voriconazole inhalation powder and tac-lac inhalation powder. the company plans to add to this pipeline by collaborating with large pharmaceutical partners. the tff platform is protected by 42 patents issued or pending in the us and internationally.